Naropin 2mg / 5mg / 7.5mg / 10mg injection
PDF Leaflet Revision Date: 27 July 2012
Clinical Summary
Quick overview from the medicine insert
Indication
Indicated for surgical anaesthesia and acute pain management.
Dosage (summary)
Adults: 2-10 mg/ml; Children: 2-5 mg/ml based on age and weight.
Onset of Action / Duration
Onset: 10-20 mins, Duration: 3-6 hours.
Special Populations
- Elderly
- Paediatric patients
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established; use with caution.
Key Drug Interactions
- CYP1A2 inhibitors (e.g., fluvoxamine)
- Other amide-type local anaesthetics
Contraindications
- Hypersensitivity to amide local anaesthetics
- Uncorrected hypotension
- Infection at injection site
Common side effects
- Hypotension
- Nausea
- Bradycardia
- Urinary retention
Counselling Points
- Monitor for CNS toxicity signs
- Avoid rapid injection
- Ensure resuscitation equipment is available
Serious warnings
- Risk of systemic toxicity
- Cardiac arrest possible
- Epidural/spinal haematomas with anticoagulants
Important Disclaimer
The Naropin 2mg / 5mg / 7.5mg / 10mg injection professional information leaflet below is the property of Aspen Pharmacare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
